Replay available

Atento S.A. Ordinary Shares (ATTO) Q3 2022 Earnings Call

Atento S.A. Ordinary Shares (NYSE: ATTO) Q3 2022 earnings conference call, held 2022-11-16. Replay captured from the company's public earnings webcast.

Wed, November 16, 2022 at 8:30 AMendedReplay
Atento S.A. Ordinary Shares (ATTO) Q3 2022 Earnings Call

Investor webinar replay

Latest press releases

Companies on this event

Featured Presenters

Declan Hamlin

Analyst (Santander)

Vincent Colicchio

Analyst (Barrington Research)

Carlos Lopez Abadía

Chief Executive Officer

Beltran Palazuelo

Analyst (Delta)

Sergio Pasos

Chief Financial Officer

Hernan Von Waveren

Investor Relations Director

Replay transcript excerpt

Good morning, and welcome to the Attento third quarter 2022 results conference call. Today's call is being recorded. All participants will be in listen-only mode. Should you need assistance, please signal a conference specialist by pressing the star key followed by zero. After today's presentation, there will be an opportunity to ask questions. To ask a question, you may press star then one on your touch-tone phone. To withdraw your question, please press star then two. If you are at your computer, please use the submit a question box in your webcast viewer. I would now like to turn the conference over to Mr. Hernan Von Waveren, Investor Relations Director for Attento. Please go ahead. Thank you, Operator, and welcome everyone to our fiscal third quarter 2022 earnings call to discuss Attento's financial and operating results. Here with us for today's call are Carlos Lopez Abadía, ATENTOS Chief Executive Officer, and Sergio Pasos, Chief Financial Officer. Following a review of ATENTOS financial and operating results, we will open the call for your questions. Before proceeding, please note that certain comments made on this call will contain financial information that has been prepared under international financial reporting standards. In addition, this call may contain information that constitutes forward-looking statements, which are not guarantees of future performance and involve risks and uncertainties. Certain results may differ materially from those in the forward-looking statements as a result of various factors. We encourage you to review our publicly available disclosure documents filed with the relevant securities regulators, and we invite you to read the complete disclosure included here on the second slide of our earnings call presentation. Our public fili...

More from Attovia Therapeutics, Inc.